Efficacy and safety of once-weekly dulaglutide versus insulin glargine in mainly Asian patients with type 2 diabetes mellitus on metformin and/or a sulphonylurea: A 52-week open-label, randomized phase III trial

Wang, WQ; Nevarez, L; Filippova, E; Song, KH; Tao, B; Gu, LQ; Wang, F; Li, PF; Yang, J

Yang, J (reprint author), Lilly Suzhou Pharmaceut Co Ltd, Dept Med, 19F,Ctr T1,HKRI Taikoo 288,Shimen 1 Rd, Shanghai 200041, Peoples R China.

DIABETES OBESITY & METABOLISM, 2019; 21 (2): 234

Abstract

Aim To compare the efficacy and safety of once-weekly dulaglutide with that of insulin glargine in combination with metformin and/or a sulphonylurea i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索